News

1. Creative BioTherapeutics Named 2026 Prix Galien USA Best Startup Nominee for Work Advancing CBT300

   Recognition marks a new chapter for the oncology-focused biotechnology company as it continues development of its investigational biologic candidate targeting mechanisms associated with cancer recurrence and treatment resistance.

2. hyperCORE International Welcomes New Officers to Power Growth for Site Networks and CROs

   New officers join the executive team to support governance and sustainable growth through the power of partnership

3. Lee Lorenzen Explains Why Better Measurement Could Be Science's Next Big Advantage

   Rancho Santa Margarita researcher Lee Lorenzen reflects on how advances in scientific measurement can give researchers new ways to test old questions, revisit unexplained observations, and strengthen experimental research.

4. Philip Ashton-Rickardt Says the Best Scientific Leaders Know When to Change Course

   The biotech executive and immunologist argues that strong R&D leadership depends as much on flexibility as conviction.

5. Creative Biolabs Connects Glycoprotein Development With Glycan Analysis

   An integrated workflow links glycoprotein design and production with analytical strategies for investigating glycosylation heterogeneity and structural variation.

6. Creative Biolabs Announces Therapeutic Antibody Engineering Services for Preclinical Development

   Creative Biolabs today announced the availability of its therapeutic antibody engineering services.

7. Creative Biolabs Expands AI-Assisted CAR/TCR Development Services

   Creative Biolabs expands its CAR/TCR development capabilities with AI-driven solutions designed to support receptor candidate screening, prioritize engineered T-cell designs, and identify potential safety and specificity risks earlier in development.

8. Creative Biolabs Expands Antibody Portfolio for HIV and HTLV Research

   Creative Biolabs has expanded its specialized antibody portfolio targeting structural and envelope proteins from HIV-1, HIV-2, and HTLV-1.

9. Creative Biolabs Expands R&D Services for Edible Plant-Derived Extracellular Vesicles

   Creative Biolabs officially announced today the expansion of its plant-derived extracellular vesicle development platform to support advancing research in natural nanoscale delivery systems.

10. Creative Biolabs Highlights Integrated Bispecific ADC Development Services for Biparatopic Programs

    Creative Biolabs, a global CRO specializing in antibody-drug conjugates (ADCs), is highlighting its integrated bispecific and biparatopic ADC development capabilities.